Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00281580 · ClinicalTrials.gov registry record · Phase 3
Telmisartan (Micardis) and Amlodipine (Norvasc) - Factorial Design Study for the Treatment of Hypertension
A Phase 3 study, sponsored by Boehringer Ingelheim.
- Completed
- Registry status
- Phase 3
- Development phase
- 1,461
- Enrollment target
NCT00281580: Completed Phase 3 study, sponsored by Boehringer Ingelheim.
NCT00281580 is a Phase 3 study that has completed, run by Boehringer Ingelheim. The registered enrollment target is 1,461 participants, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (89% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00281580, a Phase 3 study, has completed, sponsored by Boehringer Ingelheim.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,461 participants
- Enrollment target
Study Summary
To demonstrate that Micardis and Norvasc when used together are more effective at lowering blood pre ssure.
Primary Outcome
Observed results
Interventions
- DRUG Placebo
- DRUG Amlodipine 5 mg
- DRUG Telmisartan 20 mg
- DRUG Telmisartan 40 mg
- DRUG Amlodipine 10 mg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,461 participants |
| Start Date | 2006-04 |
| Phase | Phase 3 |
What the finished NCT00281580 record still lists
NCT00281580 is an interventional study that assigns participants to a tested intervention. Its 1,461 participants enrollment target places it among the larger protocols in the corpus, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (89% higher).
The record links to 0 conditions, and to 5 interventions - of which Placebo is the first listed.
NCT00281580 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00281580 about?
NCT00281580 is a clinical study titled "Telmisartan (Micardis) and Amlodipine (Norvasc) - Factorial Design Study for the Treatment of Hypertension". To demonstrate that Micardis and Norvasc when used together are more effective at lowering blood pre ssure.
What is the current status of trial NCT00281580?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,461 participants. The study started on 2006-04.
What interventions are being tested in trial NCT00281580?
The interventions under investigation include: Placebo (DRUG), Amlodipine 5 mg (DRUG), Telmisartan 20 mg (DRUG), Telmisartan 40 mg (DRUG), Amlodipine 10 mg (DRUG).
Who is sponsoring clinical trial NCT00281580?
This trial is sponsored by Boehringer Ingelheim, which has 515 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00281580's enrollment target sits among peer trials
1,461 164th of 2000 higher than 1,837 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03936361 · 1,456 participants · Phase 3
Statins In Intracerbral Hemorrhage
- NCT06782347 · 1,454 participants · NA
Activating SilverSneakers Benefits for Seniors With Osteoarthritis
- NCT04566328 · 1,450 participants · Phase 3
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
- NCT05229341 · 1,450 participants · NA
Evaluation of DNA Methylation Signatures for the Diagnosis and Management of Thyroid Nodules
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia